These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19908933)

  • 1. Impaired insulin secretion and uptake in patients with diffuse idiopathic skeletal hyperostosis.
    Eckertova M; Krskova K; Penesova A; Radikova Z; Zlnay D; Rovensky J; Zorad S
    Endocr Regul; 2009 Oct; 43(4):149-55. PubMed ID: 19908933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index and blood glucose: correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH).
    Denko CW; Malemud CJ
    Rheumatol Int; 2006 Feb; 26(4):292-7. PubMed ID: 15703952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone secretion in diffuse idiopathic skeletal hyperostosis.
    Altomonte L; Zoli A; Mirone L; Marchese G; Scolieri P; Barini A; Magarò M
    Ann Ital Med Int; 1992; 7(1):30-3. PubMed ID: 1524945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH).
    Denko CW; Boja B; Malemud CJ
    Front Biosci; 2002 Apr; 7():a37-43. PubMed ID: 11897552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term low-dose growth hormone administration in subjects with impaired glucose tolerance and the metabolic syndrome: effects on beta-cell function and post-load glucose tolerance.
    Yuen K; Wareham N; Frystyk J; Hennings S; Mitchell J; Fryklund L; Dunger D
    Eur J Endocrinol; 2004 Jul; 151(1):39-45. PubMed ID: 15248820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diffuse idiopathic skeletal hyperostosis and its relation to metabolic parameters].
    Pavelková A; Pavelka K
    Vnitr Lek; 2006 May; 52(5):477-80. PubMed ID: 16771094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis--insulin, insulin-like growth factor-I, growth hormone.
    Denko CW; Boja B; Moskowitz RW
    J Rheumatol; 1994 Sep; 21(9):1725-30. PubMed ID: 7799357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum adiponectin levels in patients with diffuse idiopathic skeletal hyperostosis (DISH).
    Mader R; Novofastovski I; Schwartz N; Rosner E
    Clin Rheumatol; 2018 Oct; 37(10):2839-2845. PubMed ID: 30121711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Forestier disease and metabolism disorders. A prospective controlled study of 25 cases].
    Troillet N; Gerster JC
    Rev Rhum Ed Fr; 1993 Apr; 60(4):274-9. PubMed ID: 8167624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency.
    Ciresi A; Cicciò F; Radellini S; Giordano C
    Growth Horm IGF Res; 2016 Aug; 29():71-77. PubMed ID: 27235725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced circulating stem cells associate with excess fasting and post-load NEFA exposure in healthy adults with normal glucose tolerance.
    Fadini GP; Tura A; Pacini G; Avogaro A; Vigili de Kreutzenberg S
    Atherosclerosis; 2017 Jun; 261():117-123. PubMed ID: 28298252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exposure to non-esterified fatty acid on progressive deterioration of insulin secretion in patients with Type 2 diabetes: a long-term follow-up study.
    Morita S; Shimajiri Y; Sakagashira S; Furuta M; Sanke T
    Diabet Med; 2012 Aug; 29(8):980-5. PubMed ID: 22221293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
    Damjanovic SS; Lalic NM; Pesko PM; Petakov MS; Jotic A; Miljic D; Lalic KS; Lukic L; Djurovic M; Djukic VB
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse idiopathic skeletal hyperostosis in diabetes mellitus, impaired glucose tolerance and obesity.
    Coaccioli S; Fatati G; Di Cato L; Marioli D; Patucchi E; Pizzuti C; Ponteggia M; Puxeddu A
    Panminerva Med; 2000 Dec; 42(4):247-51. PubMed ID: 11294086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-esterified fatty acid dynamics during oral glucose tolerance test in women with former gestational diabetes.
    Tura A; Pacini G; Winhofer Y; Bozkurt L; Di Benedetto G; Morbiducci U; Roden M; Kautzky-Willer A
    Diabet Med; 2012 Mar; 29(3):351-8. PubMed ID: 21988496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma non-esterified fatty acid levels and insulin secretion in non-diabetic relatives of type 2 diabetic patients.
    Butler TJ; Barriocanal LA; Walker M
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):349-55. PubMed ID: 11589678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of endogenous NEFA on beta cell function in humans.
    Rebelos E; Seghieri M; Natali A; Balkau B; Golay A; Piatti PM; Lalic NM; Laakso M; Mari A; Ferrannini E
    Diabetologia; 2015 Oct; 58(10):2344-51. PubMed ID: 26160433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factors, glucose and insulin kinetics after low dose growth hormone therapy in HIV-lipodystrophy.
    Haugaard SB; Andersen O; Flyvbjerg A; Ørskov H; Madsbad S; Iversen J
    J Infect; 2006 Jun; 52(6):389-98. PubMed ID: 16249033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.